Flinton Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$193K Sell
5,280
-48
-0.9% -$1.9K 0.01% 677
2019
Q2
$248K Sell
5,328
-1,392
-21% -$65.4K 0.01% 644
2019
Q1
$270K Buy
6,720
+208
+3% +$9.33K 0.01% 617
2018
Q4
$299K Sell
6,512
-1,328
-17% -$64K 0.01% 561
2018
Q3
$348K Buy
7,840
+6,800
+654% +$312K 0.01% 598
2018
Q2
$41K Sell
1,040
-9,056
-90% -$458K ﹤0.01% 818
2018
Q1
$730K Buy
10,096
+7,648
+312% +$562K 0.02% 340
2017
Q4
$161K Sell
2,448
-1,776
-42% -$95.6K 0.01% 696
2017
Q3
$212K Sell
4,224
-512
-11% -$24.7K 0.01% 605
2017
Q2
$219K Sell
4,736
-1,600
-25% -$58.8K 0.01% 558
2017
Q1
$224K Hold
6,336
0.01% 476
2016
Q4
$79K Buy
+6,336
New +$75.4K ﹤0.01% 644

Other funds holding ESPR